Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
Launched by CHINESE PLA GENERAL HOSPITAL · Dec 7, 2024
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called ultrasound-guided thermal ablation for people with benign thyroid nodules, which are non-cancerous lumps in the thyroid gland. The goal is to see how effective this treatment is over the long term, especially for those who have concerns about their nodules causing cosmetic or symptom issues, or who may not be eligible or willing to have surgery.
To participate in this trial, individuals need to have confirmation from two separate tests that their nodules are benign, and they should not show any signs of cancer on ultrasound. Participants must also be at least 65 years old and have a follow-up period of at least 12 months. Throughout the trial, participants can expect regular check-ups to monitor their condition and see how well the treatment works. This trial is currently recruiting participants of all genders who meet the eligibility criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy
- • 2. no suspicious malignant features on ultrasound examination
- • 3. report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation
- • 4. refusal or ineligibility for surgery
- • 5. follow-up time ≥12 months
- Exclusion Criteria:
- • 1. follicular neoplasm or malignancy findings on biopsy
- • 2. nodules with benign result on biopsy had suspicious of malignancy in US
- • 3. patients with contra-lateral vocal cord paralysis
- • 4. previous radiation to the head and neck
- • 5. follow- up time less than 12 months
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yukun Luo
Principal Investigator
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported